| AC | Adenylate Cyclase |
| ACE | Angiotensin-Converting Enzyme |
| ADA | American Diabetes Association |
| Akt | Protein Kinase B |
| ALT | Alanine Aminotransferase |
| ASCVD | Atherosclerotic Cardiovascular Disease |
| AST | Aspartate Aminotransferase |
| cAMP | Cyclic Adenosine Monophosphate |
| CNS | Central Nervous System |
| COPD | Chronic Obstructive Pulmonary Disease |
| CRMS | Cardio–Renal–Metabolic Syndrome |
| CVOT | Cardiovascular Outcome Trial |
| DKD | Diabetic Kidney Disease |
| DN | Diabetic Nephropathy |
| DPP-4 | Dipeptidyl Peptidase-4 |
| EPAC | Exchange Protein Directly Activated By Camp |
| FDA | Food And Drug Administration |
| GCGR | Glucagon Receptor |
| GFR | Glomerular Filtration Rate |
| GIP | Glucose-Dependent Insulinotropic Polypeptide |
| GIPR | GIP Receptor |
| GLP-1 | Glucagon-Like Peptide-1 |
| GLP-1R | GLP-1 Receptor |
| GLP-1RA | GLP-1 Receptor Agonist |
| GLUT-4 | Glucose Transporter Type 4 |
| GPCR | G Protein-Coupled Receptor |
| HbA1c | Glycated Hemoglobin |
| HDL | High-Density Lipoprotein |
| HFpEF | Heart Failure With Preserved Ejection Fraction |
| HSA | Human Serum Albumin |
| IR | Insulin Resistance |
| IRS-1 | Insulin Receptor Substrate 1 |
| LDL | Low-Density Lipoprotein |
| MACE | Major Adverse Cardiovascular Events |
| MASH | Metabolic Dysfunction-Associated Steatohepatitis |
| MASLD | Dysfunction-Associated Steatotic Liver Disease |
| MI | Myocardial Infarction |
| NAFLD | Non-Alcoholic Fatty Liver Disease |
| NAION | Non-Arteritic Anterior Ischemic Optic Neuropathy |
| PEG | Polyethylene Glycol |
| PI3K | Phosphoinositide 3-Kinase |
| PLGA | Poly(Lactic-Co-Glycolic Acid) |
| PKA | Protein Kinase A |
| PKCβ | Protein Kinase C Beta |
| PPAR-α | Peroxisome Proliferator-Activated Receptor Alpha |
| RAAS | Renin–Angiotensin–Aldosterone System |
| Ro5 | Lipinski’s Rule Of Five |
| SGLT2 | Sodium-Glucose Cotransporter 2 |
| SGLT2i | Sodium–Glucose Cotransporter 2 Inhibitors |
| SNAC | Sodium N-[8-(2-Hydroxybenzoyl)Aminocaprylate] |
| SPPS | Solid-Phase Peptide Synthesis |
| T2DM | Type 2 Diabetes Mellitus |
| WHO | World Health Organization |
| (AEEA)2 | [2-(2-(2-aminoethoxy) ethoxy) acetic acid]2 |
| (Oda)2 | (2,2′-Oxydiacetic acid)2 |